The Fate of Afrezza is now in the hands of the Diabetics
Aug 20, 2014 9:08:23 GMT -5
jpg, mannmade, and 4 more like this
Post by rockstarrick on Aug 20, 2014 9:08:23 GMT -5
A post I shared on YMB
Step 1) October 14 2013 Mannkind files the NDA that was drafted by the FDA for possible appoval of Afrezza.
Step 2) The FDA acknowledges the new NDA filed by Mannkind.
Step3) The FDA schedules an Advisory Committee to discuss the safety and efficacy of Afrezza.
Step4) The ADCOM panel of Diabetic Royalty was assembled by the FDA.
Step 5) The ADCOM members vote unanimously (27to1) to approve Afrezza.
Step6) The FDA issues a standard 90 day delay to analyze the data of the ADCOM.
Step7) The FDA approves Afrezza earlier than expected.( June 27)
Step 8) Mannkind and the FDA hash out the clean label for Afrezza.
Step 9) Mannkind secures a 5 year Global manufacturing deal with AMPH Pharmaceuticals.
Step 10) Mankind secures a partnership deal with Sanofi to distribute Afrezza, Sanofi has a diabetes sales force 50,000 strong, in 120 Countries and I won't even mention the split and money.
Afrezza's fate will now be in the hands of the Diabetic population all over the World !!! We have cleared the last hurdle, the people who count will get to decide the fate of Afrezza. All we have to do is wait a little longer and the people will let us know our fate, we are going to market with one of the major Diabetes Companies in the world. How can anybody not see this as positive ?? Mannkind, in my opinion, did everything they could do, and they did it very well. No BP has ever successfully pulled off what Mannkind just did.
As Sanofi prepares to launch Afrezza, Mannkind Technologies will be conducting studies for future applications of Technosphere. Just give it a little time. We won, the long term vs the short term will pay.
We have waited this long, what's a few more months to get it done right. Good Luck too all Mannkind longs. RSR Less Less
Step 1) October 14 2013 Mannkind files the NDA that was drafted by the FDA for possible appoval of Afrezza.
Step 2) The FDA acknowledges the new NDA filed by Mannkind.
Step3) The FDA schedules an Advisory Committee to discuss the safety and efficacy of Afrezza.
Step4) The ADCOM panel of Diabetic Royalty was assembled by the FDA.
Step 5) The ADCOM members vote unanimously (27to1) to approve Afrezza.
Step6) The FDA issues a standard 90 day delay to analyze the data of the ADCOM.
Step7) The FDA approves Afrezza earlier than expected.( June 27)
Step 8) Mannkind and the FDA hash out the clean label for Afrezza.
Step 9) Mannkind secures a 5 year Global manufacturing deal with AMPH Pharmaceuticals.
Step 10) Mankind secures a partnership deal with Sanofi to distribute Afrezza, Sanofi has a diabetes sales force 50,000 strong, in 120 Countries and I won't even mention the split and money.
Afrezza's fate will now be in the hands of the Diabetic population all over the World !!! We have cleared the last hurdle, the people who count will get to decide the fate of Afrezza. All we have to do is wait a little longer and the people will let us know our fate, we are going to market with one of the major Diabetes Companies in the world. How can anybody not see this as positive ?? Mannkind, in my opinion, did everything they could do, and they did it very well. No BP has ever successfully pulled off what Mannkind just did.
As Sanofi prepares to launch Afrezza, Mannkind Technologies will be conducting studies for future applications of Technosphere. Just give it a little time. We won, the long term vs the short term will pay.
We have waited this long, what's a few more months to get it done right. Good Luck too all Mannkind longs. RSR Less Less
